• Contact us

    Get in touch with Life Sciences Scotland

  • Life Sciences Advisory Board

    Developing and driving the overall life sciences strategy in Scotland

Life Sciences Advisory Board (LiSAB)

LiSAB is a joint industry, enterprise and government strategy team that plays a crucial role in ensuring Scotland has the best possible environment for fledgling technologies and established players alike. It fosters support and discussion between key players in the life sciences sector and those responsible for government policy-making at the very highest level.

LiSAB has a very active remit; to develop and drive overall life sciences strategy in Scotland; developing an environment where ingenuity and innovation can create jobs and wealth for Scotland, as well as genuine benefits for the global community.

LiSAB consists of representatives across the spectrum of the life science community: CEOs and senior managers from pharmaceutical, biotechnology, medical devices and diagnostics companies; research organisations; Scottish Enterprise, Highlands and Islands Enterprise, the Scottish Government, Universities and the NHS.

LiSAB’s remit is:

  • To set the overall strategy for the growth of the Life Sciences sector in Scotland.

  • To advise Ministers, government, Scottish Enterprise, HIE and the wider public sector on key issues the industry is facing, both in Scotland and internationally.

  • To advise on the deliverables that will help the Life Sciences industry to fulfil its growth potential.

Life Sciences Advisory Board members

Name Company/organisation
John Brown (Co-Chair) Roslin Foundation
Nicola Sturgeon (Co-Chair) Deputy First Minister and Cabinet Secretary for Health & Wellbeing
Rhona Allison Scottish Enterprise
Brian Bathgate Charles River Laboratories
David Bowie Aircraft Medical
Chris Hill MSD
Steven Dodsworth Highlands & Islands Enterprise
Anne Glover Chief Scientific Adviser
Paul McBarron Cyclacel
Aileen McKechnie Scottish Government
Stuart Mead Touch Bionics
Andrew Morris University of Dundee
Scott Johnstone Antoxis
Simon Jose GSK
Andrew Mearns-Spragg Aquapharm
Colin Morgan J&J Medical UK
Chris Packard NHS GG&C
Tom Shepherd CXR Biosciences
Alison Spaull Chief Scientist Office
Alistair Strachan Pfizer
David Venables Intercell
George Zajiceck Axis-Shield